
NIH-supported Phase 1 trial of potential broadly protective vaccine.
Bethesda, Maryland—(ENEWSPF)—September 18, 2018
Contact: Anne A. Oplinger
An early-stage clinical trial testing the safety and immune-stimulating ability of an experimental nasal influenza vaccine in healthy 9- to 17-year-old children and teens has begun enrolling participants at a Vaccine and Treatment Evaluation Unit(VTEU) site…






